Sintx Technologies, Inc. (SINT) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
27/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSINT / S&P -25.29% / 15.20% |
LoseSINT / S&P -28.53% / 15.00% |
LoseSINT / S&P 2.94% / 50.40% |
| 2026-Q10/3 |
LoseSINT / S&P -35.16% / -4.33% |
LoseSINT / S&P -59.95% / 11.30% |
LoseSINT / S&P -32.17% / 27.70% |
| 2025-Q40/3 |
LoseSINT / S&P -5.62% / 2.65% |
LoseSINT / S&P -64.74% / 9.00% |
LoseSINT / S&P -79.70% / 13.40% |
| 2025-Q31/3 |
WinSINT / S&P 27.02% / 8.12% |
LoseSINT / S&P -60.89% / 4.61% |
LoseSINT / S&P -97.45% / 13.45% |
| 2025-Q21/3 |
WinSINT / S&P 21.05% / 10.94% |
LoseSINT / S&P -40.47% / 4.83% |
LoseSINT / S&P -97.66% / 10.63% |
| 2025-Q10/3 |
LoseSINT / S&P -24.00% / -4.27% |
LoseSINT / S&P -7.42% / 4.98% |
LoseSINT / S&P -97.90% / 10.57% |
| 2024-Q42/3 |
WinSINT / S&P 7.36% / 2.41% |
WinSINT / S&P 9.90% / 5.25% |
LoseSINT / S&P -91.70% / 6.15% |
| 2024-Q31/3 |
LoseSINT / S&P -32.08% / 5.89% |
WinSINT / S&P 30.40% / 5.89% |
LoseSINT / S&P -85.74% / 6.11% |
| 2024-Q21/3 |
LoseSINT / S&P -52.00% / 4.28% |
WinSINT / S&P 39.68% / 5.38% |
LoseSINT / S&P 3.92% / 5.12% |
| 2024-Q12/3 |
LoseSINT / S&P -86.88% / 10.56% |
WinSINT / S&P 40.86% / 5.71% |
WinSINT / S&P 595.79% / 5.59% |
| 2023-Q42/3 |
LoseSINT / S&P -52.96% / 11.69% |
WinSINT / S&P 68.40% / 6.81% |
WinSINT / S&P 578.30% / 7.78% |
| 2023-Q32/3 |
LoseSINT / S&P -34.15% / -3.27% |
WinSINT / S&P 159.38% / 7.52% |
WinSINT / S&P 464.56% / -5.03% |
| 2023-Q22/3 |
LoseSINT / S&P -40.00% / 8.74% |
WinSINT / S&P 189.52% / 9.50% |
WinSINT / S&P 289.48% / -8.57% |
| 2023-Q12/3 |
LoseSINT / S&P -78.82% / 7.50% |
WinSINT / S&P 210.73% / 10.77% |
WinSINT / S&P 27.84% / -15.69% |
| 2022-Q42/3 |
LoseSINT / S&P -69.75% / 7.56% |
WinSINT / S&P 157.43% / 11.88% |
WinSINT / S&P 23.82% / -17.99% |
| 2022-Q32/3 |
LoseSINT / S&P -26.10% / -4.88% |
WinSINT / S&P 72.35% / 13.47% |
WinSINT / S&P 22600.00% / -1.41% |
| 2022-Q22/3 |
LoseSINT / S&P -29.02% / -16.10% |
WinSINT / S&P 101.30% / 13.71% |
WinSINT / S&P 18529.63% / 11.04% |
| 2022-Q12/3 |
LoseSINT / S&P -4.98% / -4.60% |
WinSINT / S&P 30.18% / 15.97% |
WinSINT / S&P 7435.85% / 42.23% |
| 2021-Q41/3 |
LoseSINT / S&P -49.84% / 11.03% |
LoseSINT / S&P 2.19% / 15.00% |
WinSINT / S&P 1947.69% / 96.40% |
| 2021-Q30/3 |
LoseSINT / S&P -33.33% / 0.58% |
LoseSINT / S&P -23.59% / 10.77% |
LoseSINT / S&P -86.22% / 69.42% |
| 2021-Q20/3 |
LoseSINT / S&P 2.67% / 8.55% |
LoseSINT / S&P -54.07% / 6.58% |
LoseSINT / S&P -90.22% / 51.81% |
| 2021-Q11/3 |
WinSINT / S&P 19.11% / 6.17% |
LoseSINT / S&P -39.05% / -1.06% |
LoseSINT / S&P -91.72% / 7.39% |
| 2020-Q40/3 |
LoseSINT / S&P -18.23% / 12.15% |
LoseSINT / S&P -13.93% / -3.72% |
LoseSINT / S&P -72.57% / -33.42% |
| 2020-Q30/3 |
LoseSINT / S&P 1.05% / 8.93% |
LoseSINT / S&P SINT unavailable / -2.04% |
LoseSINT / S&P -116.57% / -27.10% |
| 2020-Q21/3 |
WinSINT / S&P 373.82% / 20.54% |
LoseSINT / S&P SINT unavailable / -0.46% |
LoseSINT / S&P -86.79% / -27.11% |
| 2020-Q10/3 |
LoseSINT / S&P -73.09% / -19.60% |
LoseSINT / S&P SINT unavailable / 3.47% |
LoseSINT / S&P -87.86% / -14.75% |
| 2019-Q40/3 |
LoseSINT / S&P -25.87% / 9.07% |
LoseSINT / S&P SINT unavailable / 5.36% |
LoseSINT / S&P -86.21% / 2.99% |
| 2019-Q30/3 |
LoseSINT / S&P -21.18% / 1.70% |
LoseSINT / S&P SINT unavailable / 5.02% |
LoseSINT / S&P SINT unavailable / 0.21% |
| 2019-Q20/3 |
LoseSINT / S&P -55.26% / 4.30% |
LoseSINT / S&P SINT unavailable / 6.64% |
LoseSINT / S&P SINT unavailable / 8.65% |
| 2019-Q10/3 |
LoseSINT / S&P 5.56% / 13.65% |
LoseSINT / S&P SINT unavailable / 8.12% |
LoseSINT / S&P SINT unavailable / 14.29% |
| 2018-Q40/3 |
LoseSINT / S&P -30.23% / -13.52% |
LoseSINT / S&P SINT unavailable / 9.05% |
LoseSINT / S&P SINT unavailable / 18.23% |
| 2018-Q30/3 |
LoseSINT / S&P -72.70% / 7.71% |
LoseSINT / S&P SINT unavailable / 10.21% |
LoseSINT / S&P SINT unavailable / 19.06% |
| 2018-Q20/3 |
LoseSINT / S&P -37.83% / 3.43% |
LoseSINT / S&P -24.46% / 9.03% |
LoseSINT / S&P SINT unavailable / 14.46% |
| 2018-Q10/3 |
LoseSINT / S&P -53.52% / -0.76% |
LoseSINT / S&P -20.41% / 7.68% |
LoseSINT / S&P SINT unavailable / 12.46% |
| 2017-Q40/3 |
LoseSINT / S&P -9.17% / 6.64% |
LoseSINT / S&P -26.26% / 7.03% |
LoseSINT / S&P SINT unavailable / 13.82% |
| 2017-Q30/3 |
LoseSINT / S&P -20.84% / 4.48% |
LoseSINT / S&P -25.34% / 5.68% |
LoseSINT / S&P SINT unavailable / 17.57% |
| 2017-Q20/3 |
LoseSINT / S&P -7.56% / 3.09% |
LoseSINT / S&P -29.01% / 4.83% |
LoseSINT / S&P SINT unavailable / 17.74% |
| 2017-Q10/3 |
LoseSINT / S&P -34.92% / 6.07% |
LoseSINT / S&P -27.54% / 3.67% |
LoseSINT / S&P SINT unavailable / 13.32% |
| 2016-Q40/3 |
LoseSINT / S&P -32.19% / 3.82% |
LoseSINT / S&P -21.73% / 2.09% |
LoseSINT / S&P SINT unavailable / 7.05% |
| 2016-Q30/3 |
LoseSINT / S&P -29.62% / 3.85% |
LoseSINT / S&P -14.56% / 0.20% |
LoseSINT / S&P SINT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SINT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -63.13% | 20.78% |
| Annualized return | -63.13% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SINT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.99% | 83.14% |
| Annualized return | -86.00% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | SINT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -78.18% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |